TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Fever (rectal equivalent temperature ≥ 38°C)
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity (anti-Hep B ≥ 10 mIU/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Death or severe disability at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of current smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol cut-off levels during cosyntropin stimulation tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Satisfaction with patient care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Involvement in the medical team
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: decrease in positive affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: nevirapine oral clearance (CL/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nevirapine average minimum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the concentration‐time curve of 12‐hydroxynevirapine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of ventilation in lung regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of ventilator-associated pneumonia
Endpoint domain: Mortality/survival
Primary endpoint: Intensive care mortality
Endpoint domain: Mortality/survival
Primary endpoint: incidence of lipoatrophy
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the concentration-time curve to 24 hours (AUC24) of ganciclovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inner self-confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to initial lung isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of repositioning incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in patient acceptance of the ICD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: %peak .VO(2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %HRmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise capacity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agitation in people with Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bubble scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: serum thromboxane B(2) (TXB(2)) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Breast examination performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal examination performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Professionalism during examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month physical health
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: hair analysis abstinence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASI-Lite drug use composite scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial vasodilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean root mean square of total HOAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of further retinopathy progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: I1year drinking outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early ulcer rebleeding rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-state values
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: adherence with glaucoma medications
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in NCIC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of aggressive incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of aggressive incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of lateral motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE)
Endpoint domain: Adverse events/effects
Primary endpoint: Central macula thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in FEV₁% predicted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in Pa sputum density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sodium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Nitrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: tmax of monomethylfumarate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of monomethylfumarate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tlag of monomethylfumarate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average mucosal injury score in the gastric antrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of erosive disease (erosions and/or ulcers)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric mucosal prostaglandin synthesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: MyoPS (Muscle Protein Synthesis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SarcPS (Sarcoplasmic Protein Synthesis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight bearing on the affected side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Phosphorus clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Creatinine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Morbidity of joints and circumference of the limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: thirst management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial C-peptide concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: postprandial lactate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TG/HDL-cholesterol ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-year local relapse-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: improvement in clinical syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in whole blood and plasma viscosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: improvement in gnosia and activity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increases in knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Satisfaction with educational materials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence in genetics knowledge and skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: fixation durations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined fruits and vegetables consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary glycemic index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of cardiac events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: acute-onset injuries
Endpoint domain: Adverse events/effects
Primary endpoint: acceptable balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M.tb-specific production of IFN gamma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: M.tb-specific production of IL-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: anti-CFP-10 antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dilatation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median Hegar number passed into the cervix without resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle CSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: intramuscular lipid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: maximal isometric strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Healing of oral mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone regeneration enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery as measured by the postoperative Lysholm score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corrected teething age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of erupted teeth at 2 years of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maturation of permanent teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative adhesive bowel obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: motor errors during re-acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time to baseline platelet reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of Disease Stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scintigraphic ischemia scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retina reattachment success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative intraocular pressure elevation
Endpoint domain: Adverse events/effects
Primary endpoint: Total serum protein and albumin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transient thrombocytopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in LDL cholesterol classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean heart rate during anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder relief measured by tinnitus annoyance visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Tinnitus Handicap Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quit smoking at 4 weeks
Endpoint domain: Mortality/survival
Primary endpoint: Postpolypectomy hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Average number of visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of asymptomatic DVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Improvement in personal and social functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: postoperative regularity topographic indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence and severity of postoperative haze
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of complementary/alternative medicine in asthma treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin-related quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of complaints regarding care quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of days for which the gestation was prolonged
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted mortality in patients with AVB
Endpoint domain: Mortality/survival
Primary endpoint: therapeutic benefit in patients with IBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of migraine episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: >50% reduction in migraine episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative mean blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: balance ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of F(2)-isoprostanes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentrations of protein thiols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentrations of C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentrations of interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean total cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: geometric mean immunoglobulin G antibody concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: OPA titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EQ-5D utility score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported problems in mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: self-reported problems in pain/discomfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: DAS <2.4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in EULAR and ACR scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall improvement in clinical score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognosis-related questions asked
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in bicarbonate level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to remove caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and discomfort during caries removal
Endpoint domain: Adverse events/effects
Primary endpoint: discomfort and pain during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median Progression-Free Survival Time (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Patency at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: bladder perforation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extubation failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Patient-ventilator asynchrony index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Perfect technique and knot achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Error-proneness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: FEV1 increase 60-min post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: functional visual performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in portal blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in urinary sodium excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in symptoms of functional dyspepsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric emptying improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of analgetic drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: New episodes of low back pain
Endpoint domain: Adverse events/effects
Primary endpoint: High density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic clearance rate of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Days NPO (nil per os)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of NEC (necrotizing enterocolitis)
Endpoint domain: Adverse events/effects
Primary endpoint: PASI75 maintenance at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean patient/year cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intra-graft abundance of FOXP3 mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 1-year graft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of chronic allograft nephropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Pain reported after procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Bleeding reported after procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Change to first period post-colposcopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Preoperative symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative number of RIR episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of sick-leave days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Coronary patency (TIMI flow grades 2 and 3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of new ischemic events (reinfarction, recurrent angina, ischemic stroke)
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics (PK) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacodynamics (PD) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iAUC for total peroxide oxidative status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iAUC for insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Observer's Assessment of Alertness/Sedation scores (MOAA/S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health status (SGRQ scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: modified Rankin scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiotoxicity detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean serum glycosylated hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean insulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of obstructive apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes